Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Beth-Ann Lesnikoski"'
Autor:
Eric P. Winer, J. Dirk Iglehart, Rebecca Gelman, Paula N. Friedman, Madhavi Kamma, Beth-Ann Lesnikoski, Harold J. Burstein, Steven E. Come, Paula D. Ryan, Dennis Sgroi, Xin Lu, Agnes Witkiewicz, Stuart J. Schnitt, Fanglei You, Lyndsay N. Harris
Supplementary Tables S1-S3 from Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2aad775051452735e56c07c53407c822
https://doi.org/10.1158/1078-0432.22440915.v1
https://doi.org/10.1158/1078-0432.22440915.v1
Autor:
Eric P. Winer, J. Dirk Iglehart, Rebecca Gelman, Paula N. Friedman, Madhavi Kamma, Beth-Ann Lesnikoski, Harold J. Burstein, Steven E. Come, Paula D. Ryan, Dennis Sgroi, Xin Lu, Agnes Witkiewicz, Stuart J. Schnitt, Fanglei You, Lyndsay N. Harris
Purpose: To assess pathologic complete response (pCR), clinical response, feasibility, safety, and potential predictors of response to preoperative trastuzumab plus vinorelbine in patients with operable, human epidermal growth factor receptor 2 (HER2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10039f02070371055ed4ff2c5b5f80d3
https://doi.org/10.1158/1078-0432.c.6518148
https://doi.org/10.1158/1078-0432.c.6518148
Autor:
Jorge Ferrer, David Carr, Peter Blumencranz, Irene Wapnir, Donna Dyess, Shelly Hwang, Nayana Dekhne, Daleela Dodge, Beth-Ann Lesnikoski, Kelly Hunt, Patricia Clark, Stephanie Valente, Marie Catherine Lee, Lynne Clark, Brian Schlossberg, Sean Madden, Alejandra Rodriguez, Kate Smith, Manna Chang, Barbara Smith
Publikováno v:
Cancer Research. 82:OT2-12
Background Breast-conserving surgery is a critical step in treatment with the goal of removing all cancer cells while minimizing the removal of healthy tissue. 15% to 25% of lumpectomy patients have positive margins and require a second surgery to ac
Autor:
Henry M Kuerer, Benjamin D Smith, Savitri Krishnamurthy, Wei T Yang, Vicente Valero, Yu Shen, Heather Lin, Anthony Lucci, Judy C Boughey, Richard L White, Emilia J Diego, Gaiane M Rauch, Tanya W Moseley, Raquel FD van la Parra, Beatriz E Adrada, Jessica WT Leung, Susie X Sun, Mediget Teshome, Makesha V Miggins, Kelly K Hunt, Sarah M DeSnyder, Richard A Ehlers, Rosa F Hwang, Jessica S Colen, Elsa Arribas, Laila Samiian, Beth-Ann Lesnikoski, Mathew Piotrowski, Isabelle Bedrosian, Clayton Chong, Ana P Refinetti, Monica Huang, Rosalind P Candelaria, Catherine Loveland-Jones, Melissa P Mitchell, Simona F Shaitelman
Publikováno v:
The Lancet. Oncology. 23(12)
Neoadjuvant systemic therapy (NST) for triple-negative breast cancer and HER2-positive breast cancer yields a pathological complete response in approximately 60% of patients. A pathological complete response to NST predicts an excellent prognosis and
Autor:
E Shelley, Hwang, Peter, Beitsch, Peter, Blumencranz, David, Carr, Anees, Chagpar, Lynne, Clark, Nayana, Dekhne, Daleela, Dodge, Donna L, Dyess, Linsey, Gold, Stephen, Grobmyer, Kelly, Hunt, Stephen, Karp, Beth-Ann, Lesnikoski, Irene, Wapnir, Barbara L, Smith, Sean, Madden
Publikováno v:
JAMA surgery. 157(7)
Positive margins following breast-conserving surgery (BCS) are often identified on standard pathology evaluation. Intraoperative assessment of the lumpectomy cavity has the potential to reduce residual disease or reexcision rate following standard of
Autor:
Pat W, Whitworth, Peter D, Beitsch, James V, Pellicane, Paul L, Baron, Laura A, Lee, Carrie L, Dul, Mary K, Murray, Mark A, Gittleman, Raye J, Budway, Rakhshanda Layeequr, Rahman, Pond R, Kelemen, William C, Dooley, David T, Rock, Kenneth H, Cowan, Beth-Ann, Lesnikoski, Julie L, Barone, Andrew Y, Ashikari, Beth B, Dupree, Shiyu, Wang, Andrea R, Menicucci, Erin B, Yoder, Christine, Finn, Kate, Corcoran, Lisa E, Blumencranz, William, Audeh
Publikováno v:
JCO Precision Oncology.
PURPOSE The 80-gene molecular subtyping signature (80-GS) reclassifies a proportion of immunohistochemistry (IHC)-defined luminal breast cancers (estrogen receptor–positive [ER+], human epidermal growth factor receptor 2–negative [HER2–]) as Ba
Autor:
Jennifer A. Crozier, Caitlin Hodge, Beth-Ann Lesnikoski, Laila Samiian, Todd A. Pezzi, Christopher M. Pezzi, William A. Hammond, Riccardo A. Audisio, Slavica Janeva, Amanda Devereaux
Publikováno v:
The Lancet Oncology. 21:1611-1619
There is a scarcity of data exploring the benefits of adjuvant or neoadjuvant chemotherapy in the treatment of breast cancer in older women. We aimed to explore the effect of adding chemotherapy to local therapy on overall survival in older women wit
Autor:
Caitlin Hodge, Amanda Shreders, Todd A. Pezzi, William A. Hammond, Laila Samiian, Beth-Ann Lesnikoski, Jennifer A. Crozier, Riccardo A. Audisio, Christopher M. Pezzi
Publikováno v:
Cancer Research. 80:P2-14
Purpose: The benefit of chemotherapy in older women with breast cancer is not well defined. The aim of this study was to explore the effect of chemotherapy on overall survival (OS) in women ≥ 70 years old with triple-negative breast cancer (TNBC) u
Autor:
Kate Smith, Jorge Ferrer, David Carr, Peter Blumencranz, Daleela Dodge, Nayana Dekhne, Irene Wapnir, Kelly Hunt, Linsey Gold, Stephanie Valente, Peter Beitsch, Donna Dyess, Shelly Hwang, Lynne Clark, Beth-Ann Lesnikoski, Anees Chagpar, Stephen Karp, Brian Schlossberg, Livia Gjylameti, Barbara Smith
Publikováno v:
Cancer Research. 80:OT3-06
Background: Standard surgical techniques result in positive lumpectomy margins 20-40% of the time. These positive margins require surgical re-excision which places significant burden on the healthcare system and patients. The LUM Imaging System consi
Autor:
Lynne Clark, Barbara L. Smith, Stephen E. Karp, Katherine Clegg Smith, Irene Wapnir, Sean Madden, Peter D. Beitsch, Stephanie A. Valente, W. David Lee, Donna Lynn Dyess, Nayana Dekhne, Beth-Ann Lesnikoski, Jorge Ferrer, Anees B. Chagpar, Peter W. Blumencranz, Kelly K. Hunt, David Carr, Brian Schlossberg, S Hwang, Linsey Gold, Daleela Dodge, Manna Chang, David B. Strasfeld
Publikováno v:
Cancer Research. 80:P1-20
Background: Standard surgical techniques result in positive lumpectomy margins 20-40% of the time. These positive margins require surgical re-excision which places significant burden on the healthcare system and patients. The LUM Imaging System consi